Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1996
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037214A2 Compositions of interleukin and pyrimidine nucleosides
11/28/1996WO1996037209A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
11/28/1996WO1996037208A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996WO1996037204A1 Inhibitors of farnesyl-protein transferase
11/28/1996WO1996037201A2 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY
11/28/1996WO1996023883A3 Modified ligands for receptor tyrosine kinases
11/28/1996CA2222055A1 Multimeric proteins
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2221701A1 Inhibitors of farnesyl-protein transferase
11/28/1996CA2221236A1 Methods and compositions for inhibiting 5.alpha.-reductase activity
11/28/1996CA2220971A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996CA2220837A1 Compositions of interleukin and pyrimidine nucleosides
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
11/28/1996CA2219121A1 A gene switch comprising an ecdysone receptor
11/28/1996CA2194700A1 Substituted camptothecin derivatives and process for their preparation
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0743958A1 Non-viral vector
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743951A1 Substituted lactose derivatives as cell adhesion inhibitors
11/27/1996EP0743949A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0579656B1 Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
11/27/1996EP0552243B1 Use of il-4 to treat solid tumors
11/27/1996CN1136826A Recombinant P53 adenovirus method and compositions
11/27/1996CN1136779A Long-acting injection suspensions and process for their preparation
11/27/1996CN1136777A Immunomodulating compositions from bile
11/27/1996CN1136567A Dioxide pyrrolo-pyrrolo derivatives
11/27/1996CN1136562A Estrogen excitant/antagonist
11/27/1996CN1136557A Para retinoic acid
11/27/1996CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
11/26/1996US5578742 Inhibit uncontrolled cell proliferation, treatment of psoriasis, aids, cancer, antitumor
11/26/1996US5578724 Process for preparation of benzo[f]quinolinones
11/26/1996US5578716 DNA methyltransferase antisense oligonucleotides
11/26/1996US5578612 Indole derivatives
11/26/1996US5578590 Pharmaceutical composition preparation for use in inhibiting protein kinase C
11/26/1996US5578589 Method for suppressing an immunoresponse with an estradiol derivative-chlorambucil conjugate
11/26/1996US5578571 Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
11/26/1996US5578320 Method of dehydrating liposomes using protective sugars
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/26/1996CA1338737C Porphyrins and cancer treatment
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036630A1 Tetralin compounds with mdr activity
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036622A1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
11/21/1996WO1996036612A1 Tribenzimidazoles useful as topoisomerase i inhibitors
11/21/1996WO1996036366A1 Gene therapy for effector cell regulation
11/21/1996WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996WO1996036360A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies
11/21/1996WO1996036354A2 Anticancer vaccine comprising il6/il6 receptor transfected cells
11/21/1996WO1996036335A1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents
11/21/1996WO1996029407A3 Cellubrevin homologs
11/21/1996DE19530272C1 Monoclonal antibody specific for cell-surface glyco-protein MGC-24
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2221248A1 Tribenzimidazoles useful as topoisomerase i inhibitors
11/21/1996CA2219752A1 Tetralin compounds with mdr activity
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2218898A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd19 antibodies
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/21/1996CA2194463A1 Terpenoidic derivatives useful as antitumor agents
11/20/1996EP0743301A2 Benzoylguanidines containing fluorine
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742795A1 Immuno-stimulatory monoclonal antibodies
11/20/1996EP0742789A1 Pharmaceutically active compounds and liposomes, and methods of use therof
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996EP0656783B1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin
11/20/1996EP0627009B1 Macrocyclic lactones and a productive strain thereof
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136317A Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136036A 磺酰胺衍生物 Sulfonamide derivatives
11/20/1996CN1135903A Medicine for detumescence and anticancer
11/19/1996US5576450 Process for preparing taxoids
11/19/1996US5576444 Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
11/19/1996US5576330 Mixture of an angiogenesis inhibitor and an antitumor agent
11/19/1996US5576325 Pyrrolyl-4h-pyranoquinolines
11/19/1996US5576309 Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition
11/19/1996US5576293 Inhibitors of farnesyl-protein transferase
11/19/1996US5575993 Useful as herbicides, microbiocides, plant growth regulators, pharmaceuticals, disinfectants, algicides, sanitizers, and preservatives
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/17/1996CA2176553A1 Fluorine-containing benzoylguanidines
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996WO1996035715A2 Pcna binding substance
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035681A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
1 ... 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 ... 2211